Research Paper Volume 15, Issue 9 pp 3480—3497
A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
Figure 9. Prediction of immunotherapy response. (A) The expression of immune checkpoints in low- and high-risk groups. (B) The relationship between risk score and the expression of some immune checkpoints.